2026年6月最新影响因子数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
体验更多LetPub AI科研工具 >> | |
| 近期推荐： | 热 Wiley 2026暑期线上学习营 | 报名正式开启！ | 热 多本ABS四星！优质经管国际期刊列表 | 热 全流程投稿协助套餐服务 |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH J EXP CLIN CANC RES （此期刊被最新的JCR期刊SCIE收录） LetPub评分 7.9
67人评分
我要评分
声誉 8.3 影响力 7.3 速度 9.4 | |||||||||||||||||||||
| 期刊ISSN | 1756-9966 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||
| P-ISSN | 0392-9078 | |||||||||||||||||||||
| 2025-2026最新IF （数据来源于网友提供） | 注册或登录后，查看IF | |||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日：14.28 | |||||||||||||||||||||
| 2025-2026自引率 | 1.4%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年IF （数据来源于网友提供） | 14.301数据由网友[mild行者42]收集提供 | |||||||||||||||||||||
| h-index | 67 | |||||||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | https://link.springer.com/journal/13046 | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/jecc/ | |||||||||||||||||||||
| 作者指南网址 | https://link.springer.com/journal/13046/collections | |||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Vitexin compound 1, a novel extraction from a Chinese herb, suppresses melanoma cell growth through DNA damage by increasing ROS levels (vol 37, 269, 2018) Author: Liu, Nian; Wang, Kuan Song; Qi, Min; Zhou, Ying Jun; Zeng, Guang Yao; Tao, Juan; Zhou, Jian Da; Zhang, Jiang Lin; Chen, Xiang; Peng, Cong Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2026; Vol. 45, Issue 1, pp. -. DOI: 10.1186/s13046-026-03761-z TSP50 facilitates breast cancer stem cell-like properties maintenance and epithelial-mesenchymal transition via PI3K p110α mediated activation of AKT signaling pathway (vol 43, 201, 2024) Author: Gao, Feng; Liu, Sichen; Wang, Jing; Wei, Gang; Yu, Chunlei; Zheng, Lihua; Sun, Luguo; Wang, Guannan; Sun, Ying; Bao, Yongli; Song, Zhenbo Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2026; Vol. 45, Issue 1, pp. -. DOI: 10.1186/s13046-026-03760-0 The KLF16/MYC feedback loop is a therapeutic target in bladder cancer (vol 43, 303, 2024) Author: Zheng, Lisi; Wang, Jingxuan; Han, Shan; Zhong, Li; Liu, Zefu; Li, Bin; Zhang, Ruhua; Zhou, Liwen; Zheng, Xianchong; Liu, Zhenhua; Zeng, Cuiling; Li, Ruonan; Zou, Yezi; Wang, Liqin; Wu, Yuanzhong; Kang, Tiebang Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2026; Vol. 45, Issue 1, pp. -. DOI: 10.1186/s13046-026-03744-0 Epitranscriptomic silencing of the ZC3H13/m6A axis orchestrates immunosuppressive microenvironment remodeling in renal cell carcinoma via CSF2-mediated MDSCs recruitment Author: Zheng, Jinxiu; Zhao, Xueting; Men, Qing; Zhou, Mengyi; Che, Yuxin; Liu, Shenglu; Zan, Likun; Guo, Lingzhi; Shao, Ying; Gao, Shuhua; Ma, Yanjie; Liu, Xiaofeng; Yang, Lijun; Yang, Tao Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2026; Vol. 45, Issue 1, pp. -. DOI: 10.1186/s13046-026-03742-2 | |||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH的语言要求，还能让JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH编辑和审稿人得到更好的审稿体验，让稿件最大限度地被JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评（3篇） 论文致谢（5篇） 。
提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||
OA期刊相关信息 | 文章处理费：需要（ GBP2890; USD3990; EUR3390; ） 文章处理费豁免：查看说明 其他费用：没有 期刊主题关键词：oncology、cancer、human tumours 相关链接：Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||
| 通讯方式 | BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL | |||||||||||||||||||||
| 出版商 | BioMed Central | |||||||||||||||||||||
| 涉及的研究方向 | 医学-肿瘤学 | |||||||||||||||||||||
| 出版国家或地区 | ITALY | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | Quarterly | |||||||||||||||||||||
| 出版年份 | 2008 | |||||||||||||||||||||
| 年文章数 | 317点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 99.89% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 85.17% | |||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||
  | ||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1756-9966%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 平均1月 | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 约66.66% | |||||||||||||||||||||
| 版面费/APC文章处理费信息 | 文章处理费：需要（ GBP2890; USD3990; EUR3390; ） 文章处理费豁免：查看说明 其他费用：没有 LetPub提供文章处理费（APC）支持服务，可以用人民币支付版面费啦！ | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH顺利发表。
快看看作者怎么说吧：服务好评（3篇） 论文致谢（5篇） 。 提交文稿 | |||||||||||||||||||||
| 期刊常用信息链接 | ||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Vitexin compound 1, a novel extraction from a Chinese herb, suppresses melanoma cell growth through DNA damage by increasing ROS levels (vol 37, 269, 2018) Author: Liu, Nian; Wang, Kuan Song; Qi, Min; Zhou, Ying Jun; Zeng, Guang Yao; Tao, Juan; Zhou, Jian Da; Zhang, Jiang Lin; Chen, Xiang; Peng, Cong Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2026; Vol. 45, Issue 1, pp. -. DOI: 10.1186/s13046-026-03761-z PubMed DOI |
| 2. | TSP50 facilitates breast cancer stem cell-like properties maintenance and epithelial-mesenchymal transition via PI3K p110α mediated activation of AKT signaling pathway (vol 43, 201, 2024) Author: Gao, Feng; Liu, Sichen; Wang, Jing; Wei, Gang; Yu, Chunlei; Zheng, Lihua; Sun, Luguo; Wang, Guannan; Sun, Ying; Bao, Yongli; Song, Zhenbo Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2026; Vol. 45, Issue 1, pp. -. DOI: 10.1186/s13046-026-03760-0 PubMed DOI |
| 3. | The KLF16/MYC feedback loop is a therapeutic target in bladder cancer (vol 43, 303, 2024) Author: Zheng, Lisi; Wang, Jingxuan; Han, Shan; Zhong, Li; Liu, Zefu; Li, Bin; Zhang, Ruhua; Zhou, Liwen; Zheng, Xianchong; Liu, Zhenhua; Zeng, Cuiling; Li, Ruonan; Zou, Yezi; Wang, Liqin; Wu, Yuanzhong; Kang, Tiebang Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2026; Vol. 45, Issue 1, pp. -. DOI: 10.1186/s13046-026-03744-0 PubMed DOI |
| 4. | Epitranscriptomic silencing of the ZC3H13/m6A axis orchestrates immunosuppressive microenvironment remodeling in renal cell carcinoma via CSF2-mediated MDSCs recruitment Author: Zheng, Jinxiu; Zhao, Xueting; Men, Qing; Zhou, Mengyi; Che, Yuxin; Liu, Shenglu; Zan, Likun; Guo, Lingzhi; Shao, Ying; Gao, Shuhua; Ma, Yanjie; Liu, Xiaofeng; Yang, Lijun; Yang, Tao Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2026; Vol. 45, Issue 1, pp. -. DOI: 10.1186/s13046-026-03742-2 PubMed DOI |
| 5. | RETRACTION: LncRNA CCAT1 facilitates the progression of gastric cancer via PTBP1-mediated glycolysis enhancement Author: Zhang, Cong; Wang, Huixia; Liu, Qingwei; Dai, Suli; Tian, Guo; Wei, Xintong; Li, Xiaoya; Zhao, Lianmei; Shan, Baoen Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2026; Vol. 45, Issue 1, pp. -. DOI: 10.1186/s13046-026-03737-z PubMed DOI |
| 6. | RETRACTION: Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress Author: Zhang, Xiaodong; Li, Yan; Ma, Yingbo; Yang, Liang; Wang, Tao; Meng, Xin; Zong, Zhihong; Sun, Xun; Hua, Xiangdong; Li, Hangyu Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2026; Vol. 45, Issue 1, pp. -. DOI: 10.1186/s13046-026-03728-0 PubMed DOI |
| 7. | Nanovaccines with ferroptosis, necroptosis and STING-activation for synergistic immunotherapy Author: Du, Jia-Rui; Tu, Mu-Le; Xia, Yong-Xu; Lin, Yuan-Qiang; Yang, Rui; Weng, Chang; Liu, Yi; Zhang, Hao; Wang, Hui; Feng, Wen-Jie; Teng, Deng-Ke Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2026; Vol. 45, Issue 1, pp. -. DOI: 10.1186/s13046-026-03726-2 PubMed DOI |
| 8. | Nanocarrier-mediated targeting of NF-κB and JAK/STAT signaling pathways in hepatocellular carcinoma: mechanisms and therapeutic strategies Author: Azhar, Muhammad; Duan, Yang; Ahmad, Muhammad; Wang, Haichuan Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2026; Vol. 45, Issue 1, pp. -. DOI: 10.1186/s13046-026-03715-5 PubMed DOI |
| 9. | A novel antisense lncRNA, LPCRL, functions as a molecular scaffold for the USP15/MIB1 complex to promote primary cisplatin resistance and tumor progression in lung squamous cell carcinoma Author: Luo, Peng; Lu, Dapeng; Zhang, Shuang; Dong, Wenqian; Fang, Kai; Yu, Shihao; He, Bing; Zhu, Maoxin; Wang, Yuee; Jiang, Xianliang; Wang, Baolong Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2026; Vol. 45, Issue 1, pp. -. DOI: 10.1186/s13046-026-03721-7 PubMed DOI |
| 10. | BCG-trained macrophages promote pan-anti-tumor activity through epigenetic rewiring of NOX2-ROS axis Author: Sun, Rui-ming; Yang, Yi; Lai, Yang-dian; Wang, Hai-ning; Yang, Xiao-xu; Ji, Ping; Chen, Ying-ying; Liu, Zhao-yuan; Ginhoux, Florent; Fan, Xiao-yong; Duan, Huang-qi; Shen, Hai-bo; Ye, Dan; Lu, Shun; Wang, Ying; Li, Zi-ming Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2026; Vol. 45, Issue 1, pp. -. DOI: 10.1186/s13046-026-03708-4 PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共12条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
